Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
2014 Nov 5
Archived from the original on 15 July 2009
BPC-157 demonstrates effectiveness for tendon and ligament healing in preclinical animal models, though confirmed human efficacy data does not exist in published clinical trials
This multi-receptor activation enables: GLP-1R activation enhances glucose-dependent insulin secretion and reduces appetite through hypothalamic signaling GIPR activation (highest potency: EC50 0.0643 nM) promotes insulin secretion and modulates lipid metabolism GCGR activation (EC50 5.79 nM) increases energy expenditure and promotes hepatic fat oxidation Combined receptor engagement produces dose-dependent reductions in body weight and improvements in glycemic control Research demonstrates that GLP3s balanced activation across three receptors produces superior metabolic effects compared to single or dual agonists, with phase 2 trials showing up to 24.2% weight reduction in 48 weeks[2]
What kind of weight you lose matters enormously
